Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,498 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximab-resistant head and neck cancer: The MAESTRO study.
Seiwert TY, Kochanny S, Wood K, Worden FP, Adkins D, Wade JL, Sleckman BG, Anderson D, Brisson RJ, Karrison T, Stadler WM, Vokes EE. Seiwert TY, et al. Among authors: wood k. Cancer. 2020 Jul 15;126(14):3237-3243. doi: 10.1002/cncr.32929. Epub 2020 May 4. Cancer. 2020. PMID: 32365226 Free article. Clinical Trial.
A whole-blood RNA transcript-based gene signature is associated with the development of CTLA-4 blockade-related diarrhea in patients with advanced melanoma treated with the checkpoint inhibitor tremelimumab.
Friedlander P, Wood K, Wassmann K, Christenfeld AM, Bhardwaj N, Oh WK. Friedlander P, et al. Among authors: wood k. J Immunother Cancer. 2018 Sep 18;6(1):90. doi: 10.1186/s40425-018-0408-9. J Immunother Cancer. 2018. PMID: 30227886 Free PMC article.
KRAS in Non-Small-Cell Lung Cancer-Reply.
Wood K, Hensing T, Salgia R. Wood K, et al. JAMA Oncol. 2016 Oct 1;2(10):1373-1374. doi: 10.1001/jamaoncol.2016.2347. JAMA Oncol. 2016. PMID: 27442777 No abstract available.
2,498 results